AN ADC SP F

Manufacturer
AN Co Ltd.
Effective date
2016-06-24
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:46:23

Label at a glance#

ProductAN ADC SP F
Active ingredientAdenosine
Label structure8 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Adenosine 0.04%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

SP F I) Inactive Ingredients: Water, Carbomer, Beta-Glucan, Caffeine, Avena Sativa (Oat) Kernel Extract, Hovenia Dulcis Fruit Extract, Centella Asiatica Extract/Diospyros Kaki Leaf Extract/Theobroma Cacao Extract/Chamomilla Recutita (Matricaria) Extract/Wine Extract, Glycine Soja (Soybean) Seed Extract, Origanum Vulgare Flower Extract, Octanediol (Carprylyl Glycol), Phenoxyethanol, Phenoxyethanol, Sophora Flavescens Root Extract, Scutellaria Baicalensis Root Extract, Acetyl Hexapeptide-8, Copper Tripeptide-1

SP F II) Inactive Ingredients: Sodium Silicate / Hydroxypropyl Chitosan, Water, Ipomoea Purpurea Extract/Paeonia Albiflora Flower Extract/Magnolia Liliflora Flower Extract/Lilium Candidum Flower Extract, Sodium Hydroxide, Camellia Sinensis Leaf Extract, Portulaca Oleracea Extract, Polyepsilon-Lysine

PURPOSE

OTC - PURPOSE SECTION

Purpose: Skin Protectant

WARNINGS

WARNINGS SECTION

Precautions on use: 1. Stop using the product if there are any of the following abnormal symptoms appearing after use and consult with your dermatologist as continued use can worsen the symptoms. A) If there are red spots, swelling, itchiness, or irritation B) If the above symptoms appear around the skin to which the product has been applied after being exposed to direct sunlight. 2. Precautions on storage and handling A) Make sure to close the cap after use. B) Keep out of the reach of children. C) Do not keep the product in a hot or cold place or a place getting direct sunlight. 3. Do not apply the product to any parts of the skin with wound, eczema, or dermatitis.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Suggested use and application order

INDICATIONS & USAGE SECTION

Suggested use and application order: 1. Open SP F Ⅰ until the dotted line. (try not to spill the liquid content inside) 2. Open SP F Ⅱ and mix with SP F Ⅰ. (try not to spill the liquid content inside) 3. Seal the package of SP F Ⅰ and strongly shake the package more than 10 times to mix two agents well. (turning into gel when mixed enough) 4. Apply the content over your face enough with a brush contained inside the package. 5. Regardless of individual difference, wait for 15 ~ 20 minutes. (gently fan yourself while waiting) Try not to move or speak. 6. For the first few times, your skin may feel strongly stretched and there is a difference in color change depending on area. (discharge of toxin out of the skin) Feeling of stretching may differ by individual skin condition. 7. After enough application, wash your face with warm water and then use soap to cleanse your face once again. 8. Dry your face with a dry towel.

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage & administration: Use up a single package at a time.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69153-070-022023-01-30C16284748780-1f386c649-e7f2-0266-e053-dadaa90a7c1ac2a7d362-0443-48af-9e6b-94616e27a371

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69153-070-01AN ADC SP F7 mL in 1 CONTAINERSOLUTION71
69153-070-02AN ADC SP F10 in 1 CARTONSOLUTION101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69153-070AN ADC SP F (ADENOSINE) SOLUTION [AN CO LTD.]1Legacy NDC, 2 package rows20160624_c2a7d362-0443-48af-9e6b-94616e27a371.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69153-07069153-070-01, 69153-070-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
AdenosineK72T3FS567ACTIB
Water059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e24c99df-b9e9-4c67-a472-1371e9d75b81c2a7d362-0443-48af-9e6b-94616e27a3712016-06-24WarningsExact identifier
spl id: e24c99df-b9e9-4c67-a472-1371e9d75b81
spl set id: c2a7d362-0443-48af-9e6b-94616e27a371

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.